Cargando…
Efficacy and safety of caspofungin for patients with hepatic insufficiency
BACKGROUND: To observe the changes of hepatic function and efficacy of conventional dosage of caspofungin in the treatment of patients with different Child–Pugh scores. METHODS: In total, 200 patients (Child–Pugh A group: 66 patients, Child–Pugh B group: 83 patients, Child–Pugh C group: 51 patients)...
Autores principales: | Ran, Xiaoyun, Wang, Pengfei, Zhang, An, Tang, Binfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208193/ https://www.ncbi.nlm.nih.gov/pubmed/35725403 http://dx.doi.org/10.1186/s12879-022-07527-8 |
Ejemplares similares
-
Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients
por: Cesaro, Simone, et al.
Publicado: (2007) -
Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis
por: Ullmann, Irina, et al.
Publicado: (2022) -
Multifaceted efficacy of caspofungin against fungal infections in COVID-19 patients
por: Itoh, Kazuhiro, et al.
Publicado: (2022) -
Efficacy and Safety of Caspofungin Treatment in Febrile Neutropenic Patients with Hematological Disorders: A Multicenter Consecutive Case Series
por: Itoh, Kazuhiro, et al.
Publicado: (2022) -
Nonstationary Pharmacokinetics of Caspofungin in ICU Patients
por: Borsuk-De Moor, Agnieszka, et al.
Publicado: (2020)